Larvol Delta - Confirmed-Intent-to-File-Investigational-New-Drug-IND-Application-for-Lead-ITK-Inhibitor-ATI9494-in-the-Second-Half-of-2026

ATI-9494 - Aclaris

https://www.globenewswire.com/news-release/2026/05/07/3289773/37216/en/Aclaris-Therapeutics-Reports-First-Quarter-2026-Financial-Results-and-Provides-Corporate-and-Clinical-Update.html

May 7, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next